Heska Corporation manufactures, sells, and markets veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Europe, and internationally. More Details
Reasonable growth potential with mediocre balance sheet.
Share Price & News
How has Heska's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: HSKA has not had significant price volatility in the past 3 months.
7 Day Return
US Medical Equipment
1 Year Return
US Medical Equipment
Return vs Industry: HSKA exceeded the US Medical Equipment industry which returned 16.5% over the past year.
Return vs Market: HSKA exceeded the US Market which returned 13.8% over the past year.
Price Volatility Vs. Market
How volatile is Heska's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 days ago | Simply Wall StAnnouncing: Heska (NASDAQ:HSKA) Stock Increased An Energizing 218% In The Last Five Years
3 weeks ago | Simply Wall StHave Heska Corporation (NASDAQ:HSKA) Insiders Been Selling Their Stock?
1 month ago | Simply Wall StEstimating The Fair Value Of Heska Corporation (NASDAQ:HSKA)
Is Heska undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: HSKA ($98.62) is trading above our estimate of fair value ($75.19)
Significantly Below Fair Value: HSKA is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: HSKA is unprofitable, so we can't compare its PE Ratio to the US Medical Equipment industry average.
PE vs Market: HSKA is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate HSKA's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: HSKA is good value based on its PB Ratio (3.4x) compared to the US Medical Equipment industry average (3.9x).
How is Heska forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: HSKA is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.2%).
Earnings vs Market: HSKA is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: HSKA's is expected to become profitable in the next 3 years.
Revenue vs Market: HSKA's revenue (16.6% per year) is forecast to grow faster than the US market (9.9% per year).
High Growth Revenue: HSKA's revenue (16.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: HSKA's Return on Equity is forecast to be low in 3 years time (4.5%).
How has Heska performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: HSKA is currently unprofitable.
Growing Profit Margin: HSKA is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: HSKA is unprofitable, and losses have increased over the past 5 years at a rate of 33.9% per year.
Accelerating Growth: Unable to compare HSKA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: HSKA is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (1.8%).
Return on Equity
High ROE: HSKA has a negative Return on Equity (-5.23%), as it is currently unprofitable.
How is Heska's financial position?
Financial Position Analysis
Short Term Liabilities: HSKA's short term assets ($158.4M) exceed its short term liabilities ($32.9M).
Long Term Liabilities: HSKA's short term assets ($158.4M) exceed its long term liabilities ($74.1M).
Debt to Equity History and Analysis
Debt Level: HSKA's debt to equity ratio (18.5%) is considered satisfactory.
Reducing Debt: HSKA's debt to equity ratio has increased from 3.3% to 18.5% over the past 5 years.
Debt Coverage: HSKA's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if HSKA's interest payments on its debt are well covered by EBIT.
What is Heska current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate HSKA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate HSKA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if HSKA's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if HSKA's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: HSKA is not paying a notable dividend for the US market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of HSKA's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Kevin Wilson (48 yo)
Mr. Kevin S. Wilson has been President of Heska Corporation since February 24, 2013. Mr. Wilson has been Chief Executive Officer of Heska Corporation since March 31, 2014. He served as Chief Operating Offi ...
CEO Compensation Analysis
Compensation vs Market: Kevin's total compensation ($USD609.30K) is below average for companies of similar size in the US market ($USD3.05M).
Compensation vs Earnings: Kevin's compensation has been consistent with company performance over the past year.
|CEO, President & Director||6.5yrs||US$609.30k||2.49% |
|Executive VP & CFO||1.33yrs||US$1.47m||0.039% |
|Executive VP & COO||1.08yrs||US$311.22k||0.51% |
|Chief Commercial Officer||0.42yr||US$310.34k||0.14% |
|Executive VP||0.42yr||no data||0.00015% |
|Director of Investor Relations||no data||no data||no data|
|Executive Vice President of International Diagnostics||2.42yrs||US$3.56m||0.26% |
|VP of Imaging Operations||no data||no data||no data|
|VP, General Counsel & Secretary||no data||no data||0.0020% |
|Vice President of Heska Des Moines||no data||no data||no data|
Experienced Management: HSKA's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.
|CEO, President & Director||6.5yrs||US$609.30k||2.49% |
|Independent Director||1.5yrs||US$108.80k||0.031% |
|Independent Chairman of the Board||1.92yrs||US$134.48k||0.054% |
|Independent Director||9.17yrs||US$121.98k||0.072% |
|Director||0.083yr||no data||0.014% |
|Independent Director||6.83yrs||US$113.48k||0.35% |
|Independent Director||5.67yrs||US$125.98k||0.043% |
Experienced Board: HSKA's board of directors are considered experienced (5.7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: HSKA insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 21.1%.
Heska Corporation's company bio, employee growth, exchange listings and data sources
- Name: Heska Corporation
- Ticker: HSKA
- Exchange: NasdaqCM
- Founded: 1988
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: US$931.339m
- Shares outstanding: 9.44m
- Website: https://www.heska.com
Number of Employees
- Heska Corporation
- 3760 Rocky Mountain Avenue
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|HSKA||NasdaqCM (Nasdaq Capital Market)||Yes||Public Common Stock||US||USD||Jul 1997|
|HSKN||DB (Deutsche Boerse AG)||Yes||Public Common Stock||DE||EUR||Jul 1997|
Heska Corporation manufactures, sells, and markets veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Europe, and internationally. The compa ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/09/28 04:46|
|End of Day Share Price||2020/09/25 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.